Showing 1 - 20 results of 35 for search 'G. Engelhardt', query time: 0.04s
Refine Results
-
1
Maxwell’s demon in the quantum-Zeno regime and beyond by G Engelhardt, G Schaller
Published 2018-01-01
Article -
2
Developing Vaccines to Combat Pandemic Influenza by Othmar G. Engelhardt, James S. Robertson
Published 2010-02-01
Article -
3
-
4
-
5
-
6
Dependence of the Adsorption Capacity and Thermal Stability of Y Zeolites upon Si/Al Ratio by U. Lohse, G. Engelhardt, E. Alsdorf, P. Kölsch, M. Feist, V. Patzelová
Published 1986-09-01
Article -
7
Correction: Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14. by Rachel E. Johnson, Michelle Hamill, Ruth Harvey, Carolyn Nicolson, James S. Robertson, Othmar G. Engelhardt
Published 2012-01-01
Article -
8
Permissible variation in the 3' non-coding region of the haemagglutinin genome segment of the H5N1 candidate influenza vaccine virus NIBRG-14 [corrected]. by Rachel E Johnson, Michelle Hamill, Ruth Harvey, Carolyn Nicolson, James S Robertson, Othmar G Engelhardt
Published 2012-01-01
Article -
9
-
10
-
11
-
12
-
13
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy by Robert Frank Cornell, Samuel Z. Goldhaber, Brian G. Engelhardt, Javid Moslehi, Madan Jagasia, Daryl Patton, Shelton Harrell, Robert Hall, Houston Wyatt, Greg Piazza
Published 2019-02-01
Article -
14
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies by Chung Y. Cheung, Sitara Dubey, Martina Hadrovic, Christina R. Ball, Walter Ramage, Jacqueline U. McDonald, Ruth Harvey, Simon E. Hufton, Othmar G. Engelhardt
Published 2022-09-01
Article -
15
Evaluation of the Implementation of the Dutch Breast Cancer Surveillance Decision Aid including Personalized Risk Estimates in the SHOUT-BC Study: A Mixed Methods Approach by Jet W. Ankersmid, Ellen G. Engelhardt, Fleur K. Lansink Rotgerink, Regina The, Luc J. A. Strobbe, Constance H. C. Drossaert, Sabine Siesling, Cornelia F. van Uden-Kraan
Published 2024-03-01
Article -
16
The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review by Kyra Bokkers, Michiel Vlaming, Ellen G. Engelhardt, Ronald P. Zweemer, Inge M. van Oort, Lambertus A. L. M. Kiemeney, Eveline M. A. Bleiker, Margreet G. E. M. Ausems
Published 2022-02-01
Article -
17
Contact X-ray Brachytherapy for Older or Inoperable Rectal Cancer Patients: Short-Term Oncological and Functional Follow-Up by Petra A. Custers, Barbara M. Geubels, Inge L. Huibregtse, Femke P. Peters, Ellen G. Engelhardt, Geerard L. Beets, Corrie A. M. Marijnen, Monique E. van Leerdam, Baukelien van Triest
Published 2021-12-01
Article -
18
New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide by Brendan L. Mangan, Dilan Patel, Heidi Chen, Katie S. Gatwood, Michael T. Byrne, Salyka Sengsayadeth, Stacey Goodman, Bhagirathbhai Dholaria, Adetola A. Kassim, Madan Jagasia, Wichai Chinratanalab, Kathryn A. Culos, Brian G. Engelhardt
Published 2020-11-01
Article -
19
Inventory of oncologists’ unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer by Ellen G. Engelhardt, Dóra Révész, Hans J. Tamminga, Cornelis J. A. Punt, Miriam Koopman, Bregje D. Onwuteaka-Philipsen, Ewout W. Steyerberg, Henrica C. W. de Vet, Veerle M. H. Coupé
Published 2018-12-01
Article -
20
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study by Joanna Waldock, Lingyi Zheng, Edmond J. Remarque, Alexandre Civet, Branda Hu, Sarah Lartey Jalloh, Rebecca Jane Cox, Sammy Ho, Katja Hoschler, Thierry Ollinger, Claudia Maria Trombetta, Othmar G. Engelhardt, Catherine Caillet
Published 2021-08-01
Article